Mississauga, Canada

Taracad Venkatachalam

This inventor holds 3 USPTO granted patents. Top assignees: Ares Pharmaceuticals, LLC, Wayne Hughes Institute. Active years: 2001-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taracad Venkatachalam. Retrieved from https://idiyas.com/inventor/taracad-venkatachalam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • St. Anthony, MN (US) (2001)
  • Mississagua, CA (2021)
  • Mississagua, CA (US) (2023)

Company Filing History:


Years Active: 2001-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Taracad Venkatachalam in Cancer Research

Introduction

Taracad Venkatachalam is a notable inventor based in Mississauga, Canada, recognized for his significant contributions to cancer research. He holds three patents that focus on synthetic cinchona alkaloids, which have shown promising results in combating various types of cancer. His work emphasizes the development of novel compounds that exhibit potent cytotoxic activity against human cancer cells.

Latest Patents

Venkatachalam's latest patents include "Synthetic dimeric cinchona alkaloids against cancer" and "Synthetic cinchona alkaloids against cancer." The first patent describes synthetic, novel dimeric cinchona alkaloid compounds that possess strong cytotoxic activity against human cancer cells. These compounds are effective in inhibiting cellular proliferation and inducing apoptotic cell death in various cancer types, including breast cancer, prostate cancer, leukemia, and lymphoma. The chemical structure of these compounds includes dimeric cinchona alkaloids with hydroxy group functionality, enhancing their solubility for systemic administration in cancer patients.

The second patent outlines the synthesis of novel cinchona alkaloid compounds that have demonstrated potent cytotoxic activity both in vitro and in vivo. These compounds can serve as catalysts in complex chemical reactions and exhibit broad-spectrum therapeutic efficacy against different cancer types, including malignant melanoma and non-small cell lung cancer. The chemical structure of these compounds includes trimeric cinchona alkaloids with various functional groups.

Career Highlights

Throughout his career, Venkatachalam has worked with reputable organizations such as Ares Pharmaceuticals and Wayne Hughes Institute. His research has significantly advanced the understanding of cinchona alkaloids and their applications in cancer treatment.

Collaborations

Venkatachalam has collaborated with notable professionals in the field, including Fatih M Uckun and Osmond D'Cruz. These collaborations have further enriched his research and contributed to the development of innovative cancer therapies.

Conclusion

Taracad Venkatachalam's work in the field of cancer research through his innovative patents showcases his dedication to finding effective treatments for various cancer types. His contributions are paving the way for future advancements in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…